Total Payments
$10,876
2024 Payments
$1,702
Companies
49
Transactions
643
Medicare Patients
4,640
Medicare Billing
$673,678
Payment Breakdown by Category
Food & Beverage$10,257 (94.3%)
Travel$482.94 (4.4%)
Education$136.32 (1.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,257 | 638 | 94.3% |
| Travel and Lodging | $482.94 | 1 | 4.4% |
| Education | $136.32 | 4 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $3,251 | 267 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,202 | 66 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,037 | 45 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $558.61 | 37 | $0 (2024) |
| Pulmonx Corporation | $496.01 | 2 | $0 (2022) |
| PFIZER INC. | $400.59 | 22 | $0 (2024) |
| JAZZ PHARMACEUTICALS INC. | $332.32 | 13 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $269.02 | 9 | $0 (2024) |
| Shire North American Group Inc | $248.79 | 15 | $0 (2019) |
| Actelion Pharmaceuticals US, Inc. | $229.17 | 13 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,702 | 83 | GlaxoSmithKline, LLC. ($373.75) |
| 2023 | $1,458 | 77 | GlaxoSmithKline, LLC. ($389.85) |
| 2022 | $1,530 | 54 | Pulmonx Corporation ($482.94) |
| 2021 | $359.20 | 23 | GlaxoSmithKline, LLC. ($136.21) |
| 2020 | $541.66 | 36 | GlaxoSmithKline, LLC. ($148.04) |
| 2019 | $1,999 | 133 | GlaxoSmithKline, LLC. ($564.08) |
| 2018 | $1,975 | 140 | GlaxoSmithKline, LLC. ($717.21) |
| 2017 | $1,311 | 97 | GlaxoSmithKline, LLC. ($523.45) |
All Payment Transactions
643 individual payment records from CMS Open Payments — Page 1 of 26
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $34.06 | General |
| Category: Neurology | ||||||
| 12/27/2024 | Baxter Healthcare | Hillrom - Monarch Airway Clearance System (Device) | Food and Beverage | In-kind items and services | $21.45 | General |
| Category: Airway Clearance Device | ||||||
| 12/23/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $9.18 | General |
| Category: IMMUNOLOGY | ||||||
| 12/18/2024 | SANOFI-AVENTIS U.S. LLC | DUPIXENT (Biological) | Education | In-kind items and services | $57.48 | General |
| Category: Immunology | ||||||
| 12/16/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $25.35 | General |
| Category: Respiratory | ||||||
| 12/13/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $32.23 | General |
| Category: NEUROLOGY | ||||||
| 12/13/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $11.75 | General |
| Category: RESPIRATORY | ||||||
| 12/11/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.30 | General |
| Category: RESPIRATORY | ||||||
| 12/10/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $27.26 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $3.65 | General |
| Category: RESPIRATORY | ||||||
| 12/04/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: IMMUNOLOGY | ||||||
| 11/22/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $31.33 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $21.03 | General |
| Category: Respiratory | ||||||
| 11/19/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $32.85 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $9.53 | General |
| Category: RESPIRATORY | ||||||
| 11/13/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: Respiratory | ||||||
| 11/12/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $25.06 | General |
| Category: Respiratory | ||||||
| 11/01/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $28.95 | General |
| Category: Immunology | ||||||
| 11/01/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $20.57 | General |
| Category: IMMUNOLOGY | ||||||
| 10/25/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $26.67 | General |
| Category: IMMUNOLOGY | ||||||
| 10/23/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $9.64 | General |
| Category: RESPIRATORY | ||||||
| 10/22/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $31.67 | General |
| Category: IMMUNOLOGY | ||||||
| 10/16/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $0.47 | General |
| Category: IMMUNOLOGY | ||||||
| 10/15/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $8.26 | General |
| Category: IMMUNOLOGY | ||||||
| 10/14/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,045 | 1,438 | $313,567 | $144,479 |
| 2022 | 18 | 1,141 | 1,566 | $352,354 | $160,345 |
| 2021 | 17 | 1,248 | 1,712 | $377,076 | $184,171 |
| 2020 | 17 | 1,206 | 1,786 | $401,932 | $184,683 |
Total Patients
4,640
Total Services
6,502
Medicare Billing
$673,678
Procedure Codes
67
All Medicare Procedures & Services
67 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 316 | 492 | $73,800 | $48,171 | 65.3% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 96 | 227 | $96,475 | $39,279 | 40.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 104 | 130 | $39,000 | $17,716 | 45.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 69 | 69 | $20,700 | $11,928 | 57.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 38 | 57 | $12,540 | $5,487 | 43.8% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2023 | 42 | 49 | $19,012 | $4,109 | 21.6% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 80 | 84 | $10,080 | $3,956 | 39.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 23 | 23 | $8,625 | $3,297 | 38.2% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 56 | 59 | $11,800 | $2,582 | 21.9% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 74 | 77 | $8,855 | $2,461 | 27.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 32 | 34 | $3,740 | $2,148 | 57.4% |
| 94618 | Test for exercise-induced lung stress | Office | 2023 | 44 | 47 | $3,525 | $1,220 | 34.6% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2023 | 28 | 28 | $3,500 | $977.09 | 27.9% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2023 | 32 | 51 | $1,530 | $791.01 | 51.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 11 | 11 | $385.00 | $357.50 | 92.9% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 101 | 271 | $115,175 | $48,507 | 42.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 311 | 454 | $68,100 | $44,714 | 65.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 85 | 106 | $31,800 | $14,534 | 45.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 76 | 76 | $22,800 | $13,045 | 57.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 65 | 97 | $21,340 | $8,117 | 38.0% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2022 | 59 | 78 | $30,264 | $7,109 | 23.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 35 | 36 | $13,500 | $5,758 | 42.7% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 68 | 70 | $8,400 | $3,464 | 41.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 44 | 46 | $5,060 | $3,181 | 62.9% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2022 | 69 | 71 | $8,165 | $2,346 | 28.7% |
About Ankit Gupta
Ankit Gupta is a Pulmonary Disease healthcare provider based in Norwich, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/21/2010. The National Provider Identifier (NPI) number assigned to this provider is 1023324555.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Ankit Gupta has received a total of $10,876 in payments from pharmaceutical and medical device companies, with $1,702 received in 2024. These payments were reported across 643 transactions from 49 companies. The most common payment nature is "Food and Beverage" ($10,257).
As a Medicare-enrolled provider, Gupta has provided services to 4,640 Medicare beneficiaries, totaling 6,502 services with total Medicare billing of $673,678. Data is available for 4 years (2020–2023), covering 67 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Norwich, CT
- Active Since 08/21/2010
- Last Updated 03/28/2025
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1023324555
Products in Payments
- TRELEGY ELLIPTA (Drug) $1,101
- NUCALA (Biological) $965.84
- BREO (Drug) $520.56
- ANORO (Drug) $496.75
- ZEPHYR ENDOBRONCHIAL VALVE (Device) $482.94
- OFEV (Drug) $471.07
- ACTHAR (Biological) $430.54
- XOLAIR (Biological) $404.46
- SYMBICORT (Drug) $380.47
- DUPIXENT (Biological) $313.28
- GLASSIA (Biological) $276.89
- BREZTRI (Drug) $267.69
- STIOLTO RESPIMAT (Drug) $251.95
- TEZSPIRE (Biological) $242.67
- STIOLTO (Drug) $174.23
- LONHALA MAGNAIR (Drug) $157.01
- XOLAIR (Drug) $154.15
- XYWAV (Drug) $150.27
- UPTRAVI (Drug) $146.54
- DUPIXENT (Drug) $143.56
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Norwich
Thinesh Dahanayake, Md, MD
Pulmonary Disease — Payments: $102,971
Pulmonary Disease $102,971
Setu Vora, Md, MD
Pulmonary Disease — Payments: $39,202
Pulmonary Disease $39,202
Dr. Atul Palkar, M.d, M.D
Pulmonary Disease — Payments: $10,796
Pulmonary Disease $10,796
Donna Romito, Do, DO
Pulmonary Disease — Payments: $10,006
Pulmonary Disease $10,006
Dr. Jose Angelo De Dios, M.d, M.D
Pulmonary Disease — Payments: $8,142
Pulmonary Disease $8,142
Steven Powell, Md, MD
Pulmonary Disease — Payments: $2,564
Pulmonary Disease $2,564